RSV Vaccines: What You Need to Know
As the flu and COVID continue to dominate headlines, another virus is quietly making its presence known: respiratory syncytial virus (RSV). This common respiratory virus may not be on everyone’s radar, but it should be, especially for those at high risk of severe illness.
RSV typically causes mild symptoms like a runny nose and cough, but it can be dangerous for babies, older adults, and individuals with chronic medical conditions. In fact, each year in the U.S., thousands of older adults are hospitalized and die from RSV infection.
To combat this threat, RSV vaccines are now available for those most vulnerable. For older adults, Pfizer’s Abrysvo and GSK’s Arexvy have been approved by the FDA. Pregnant women can receive the maternal Pfizer Abrysvo vaccine to protect their babies, while infants can get the preventive monoclonal antibody immunization, nirsevimab (Beyfortus).
The optimal time to get the RSV vaccine for older adults is in late summer or early fall, just before the virus starts circulating in the community. The vaccines have been shown to be effective in preventing RSV infection and severe illness.
Common side effects of the RSV vaccine include pain at the injection site, muscle or joint pain, headaches, and fatigue. While side effects are usually mild, researchers are investigating rare reactions like Guillain-Barré syndrome and atrial fibrillation.
Fortunately, RSV vaccines are typically covered by health insurance, including private plans, Medicare, and Medicaid. In addition to getting vaccinated, taking precautions like wearing masks, washing hands regularly, and avoiding sick individuals can help protect against RSV.
With RSV vaccines now available, those at high risk can take proactive steps to safeguard their health during the upcoming RSV season.